INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
145 hedge funds and large institutions have $1B invested in Insys Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 61 increasing their positions, 50 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
9% less capital invested
Capital invested by funds: $1.1B → $1B (-$94.8M)
57% less call options, than puts
Call options by funds: $32M | Put options by funds: $73.8M
Holders
145
Holding in Top 10
2
Calls
$32M
Puts
$73.8M
Top Buyers
| 1 | +$41.5M | |
| 2 | +$24.1M | |
| 3 | +$21.8M | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$19.8M |
| 5 |
Goldman Sachs
New York
|
+$18.3M |
Top Sellers
| 1 | -$25.3M | |
| 2 | -$9.67M | |
| 3 | -$8.75M | |
| 4 |
Two Sigma Investments
New York
|
-$6.86M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$5.63M |